INS and type 1 diabetes mellitus: Consequently, the patient was screened for pancreatic antibodies, they confirmed diagnosis of T1D (Glutamic acid decarboxylase (GAD) autoantibodies 611.73 kU/l, highly elevated; insulin autoantibodies – negative; tyrosine phosphatase-related islet antigen 2 (IA-2) antibodies – negative).